Instil Bio Inc
NASDAQ:TIL
Intrinsic Value
The intrinsic value of one TIL stock under the Base Case scenario is 4.44 USD. Compared to the current market price of 28.58 USD, Instil Bio Inc is Overvalued by 84%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Instil Bio Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Instil Bio Inc
Balance Sheet Decomposition
Instil Bio Inc
Current Assets | 219.3m |
Cash & Short-Term Investments | 103.7m |
Receivables | 924k |
Other Current Assets | 114.7m |
Non-Current Assets | 18.2m |
Long-Term Investments | 7.2m |
PP&E | 925k |
Other Non-Current Assets | 10.1m |
Free Cash Flow Analysis
Instil Bio Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Instil Bio Inc
Revenue
|
0
USD
|
Operating Expenses
|
-50.8m
USD
|
Operating Income
|
-50.8m
USD
|
Other Expenses
|
-27.2m
USD
|
Net Income
|
-78m
USD
|
TIL Profitability Score
Profitability Due Diligence
Instil Bio Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Instil Bio Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
TIL Solvency Score
Solvency Due Diligence
Instil Bio Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Instil Bio Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TIL Price Targets Summary
Instil Bio Inc
According to Wall Street analysts, the average 1-year price target for TIL is 121.04 USD with a low forecast of 51.51 USD and a high forecast of 189 USD.
Dividends
Current shareholder yield for TIL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one TIL stock under the Base Case scenario is 4.44 USD.
Compared to the current market price of 28.58 USD, Instil Bio Inc is Overvalued by 84%.